Search
for
Sort by
Research 30 of 105
- Alopecia Areata: Current and Emerging Therapies
- Quantitative and qualitative analysis of individual experiences post botulinum toxin injection ‐ United Kingdom Survey
- The Burden of Alopecia Areata and Management with Baricitinib in the United Arab Emirates: A Narrative Review
- Industry updates in advanced therapy medicinal products and regenerative medicine – March 2026
- Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Spironolactone May Reduce the Risk of Incident Rosacea
- The safety profiles of avacopan on microscopic polyangiitis and granulomatosis with polyangiitis: a real-world pharmacovigilance analysis
- Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database
- The Current Landscape for Direct-to-Consumer Genetic Testing: Legal, Ethical, and Policy Issues
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Androgenetic Alopecia: An Evidence-Based Treatment Update
- Low-level laser therapy as a treatment for androgenetic alopecia
- Treatment options for alopecia: an update, looking to the future
- Androgens in women
- Male Breast Cancer and 5α-Reductase Inhibitors Finasteride and Dutasteride
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- Can UK undergraduate dental programmes provide training in non-surgical facial aesthetics?
- The Post-finasteride Syndrome: Clinical Manifestation of Drug-Induced Epigenetics Due to Endocrine Disruption
- Prescribing of cyproterone acetate/ethinylestradiol in UK general practice: a retrospective descriptive study using The Health Improvement Network
- Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Progress of Phage Therapy for Acne Vulgaris
- Scientific Validation of "Clinically Proven" Claims: Compliance Focused and Global Regulatory Insights
- Comparative Efficacy of Minoxidil and 5‐Alpha Reductase Inhibitors Monotherapy for Male Pattern Hair Loss: Network Meta‐Analysis Study of Current Empirical Evidence
- SARS-CoV-2 Infection and COVID-19 Vaccination Associated with Post-Acute Alopecia: Prevalence, Clinical Patterns, and Determinants Among Saudi Adults
- Drug repurposing—a promising approach for patients with angina but non-obstructive coronary artery disease (ANOCA)
- Gender Differences in Response to COVID-19 Infection and Vaccination
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- 3D Printed Hollow Microneedles for Treating Skin Wrinkles Using Different Anti-Wrinkle Agents: A Possible Futuristic Approach